Efficacy and Safety of Urate Lowering Therapy (ULT) in CKD Patients With Gout

被引：0

作者：

Helget, Lindsay N. ^{[1
,2
]}

Davis-Karim, Anne ^{[3
]}

O'Dell, James R. ^{[1
,2
]}

Mikuls, Ted R. ^{[1
,2
]}

Newcomb, Jeff A. ^{[1
]}

Androsenko, Maria ^{[4
]}

Brophy, Mary T. ^{[4
]}

England, Bryant ^{[1
,2
]}

Ferguson, Ryan ^{[4
]}

Pillinger, Michael ^{[5
,6
]}

Neogi, Tuhina ^{[7
]}

Wu, Hongsheng ^{[4
]}

Palevsky, Paul M. ^{[8
,9
]}

机构：

[1] VA Nebraska Western Iowa Hlth Care Syst, Omaha, NE USA

[2] Univ Nebraska Med Ctr, Omaha, NE USA

[3] VA Cooperat Studies Program Clin Res Pharm Coordi, Albuquerque, NM USA

[4] VA Boston Cooperat Studies Program Coordinating C, Boston, MA USA

[5] VA New York Harbor Hlth Care Syst, New York, NY USA

[6] NYU Langone Hlth, New York, NY USA

[7] Boston Univ, Sch Med, Boston, MA USA

[8] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA

[9] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

SA-PO895

引用

下载

页码：850 / 851

页数：2

共 50 条

[21] The urate-lowering Efficacy and Safety of Febuxostat in the Treatment Hyperuricemia of Gout: The CONFIRMS trial
Dejaco, C.
Duftner, C.
JOURNAL FUR MINERALSTOFFWECHSEL, 2010, 17 (02): : 84 - 84
[22] COMPARISON OF EFFICACY AND SAFETY OF DIFFERENT ANTI-INFLAMMATORY DRUGS AT INITIATION OF URATE-LOWERING THERAPY IN PATIENTS WITH GOUT (PRELIMINARY DATA)
Chikina, M.
Eliseev, M.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1757 - 1758
[23] The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Michael A Becker
H Ralph Schumacher
Luis R Espinoza
Alvin F Wells
Patricia MacDonald
Eric Lloyd
Christopher Lademacher
Arthritis Research & Therapy, 12 (2):
[24] The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Becker, Michael A.
Schumacher, H. Ralph
Espinoza, Luis R.
Wells, Alvin F.
MacDonald, Patricia
Lloyd, Eric
Lademacher, Christopher
ARTHRITIS RESEARCH & THERAPY, 2010, 12 (02)
[25] Variation in serum urate levels in the absence of gout and urate lowering therapy
Andrew Shaffer
Elizabeth Rahn
Kenneth Saag
Amy Mudano
Angelo Gaffo
BMC Rheumatology, 5
[26] Variation in serum urate levels in the absence of gout and urate lowering therapy
Shaffer, Andrew
Rahn, Elizabeth
Saag, Kenneth
Mudano, Amy
Gaffo, Angelo
BMC RHEUMATOLOGY, 2021, 5 (01)
[27] Urate-lowering Therapy for Prevention of Gout: Prespecified Analyses from the CKD-FIX Trial
Tiku, Anushree
Boudville, Neil
Brown, Fiona
Cass, Alan
Clarke, Phiilip
Day, Richard
de Zoysa, Janak
Douglas, Bettina
Faull, Randall
Harris, David
Hawley, Carmel
Jones, Graham
Kanellis, John
Pascoe, Elaine
Palmer, Suetonia
Perkovic, Vlado
Rangan, Gopala
Reidlinger, Donna
Robison, Laura
Walker, Robert
Walters, Giles
Johnson, David
Badve, Sunil
Dalbeth, Nicola
ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1372 - 1373
[28] Adherence with urate-lowering therapy for the treatment of gout
Harrold, Leslie R.
Briesacher, Becky
Raebel, Marsha
Fouayzi, Hassan
Yood, Robert
Andrade, Susan
ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S672 - S672
[29] Treat-to-target urate lowering therapy for gout
Thorley, Jennifer
LANCET RHEUMATOLOGY, 2020, 2 (09): : E526 - E526
[30] Urate Lowering Therapy in Gout: A Systematic Literature Review
Kydd, Alison
Seth, Rakhi
Edwards, Christopher
Van der Heijde, Desiree
Bombardier, Claire
JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 958 - 958

← 1 2 3 4 5 →